1 |
Sobue T, Suzuki T, Fujimoto I, Doi O, Tateishi R, Sato T. Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habits. Jpn J Cancer Res 1991;82:33-9
DOI
|
2 |
Burghuber OC, Worofka B, Schernthaner G, Veter N, Neumann M, Dudczak R, et al. Serum neuronspecific enolase is useful marker for small cell lung cancer. Cancer 1990;65:1386-90
DOI
PUBMED
ScienceOn
|
3 |
Ferrigno D, Buccheri G, Giordan C. Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC). Lung Cancer 2003;41:311-20
DOI
ScienceOn
|
4 |
Ebert W, Muley T, Drings P. Dose the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Anticancer Res 1996;16:2161-8
|
5 |
Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, et al. Tumor markers CEA, NSE, SCC, TPA and Cypra 21.1 in resectable non-small cell lung cancer. Anticancer Res 1999;19:3613-8
|
6 |
Pujol JL, Simony J. Laurent JC, Richer G, Mary H, Bousquet J, et al. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers. Cancer Res 1989;49:2797-802
|
7 |
Jang TW, Jung MH. Diagnostic usefulness of simultaneous measurement of serum tumor markers in lung cancer patients. Tuberc Respir Dis 1995;42:322-31
DOI
|
8 |
Maeda T, Ueoka H, Tabata M, Kiura K, Shiayama T, Gemba K, et al. Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicated poor prognosis. Jpn J Clin Oncol 2000;30:534-41
DOI
ScienceOn
|
9 |
Andoh M, Gemma A, Takenaka K, Hisakatsu S, Yamada K, Usuki J, et al. Serum neuron specific enolase level as a prognostic factor in non-small cell lung cancer. Intern Med 1994;33:271-6
DOI
ScienceOn
|
10 |
Goodman MT, Kolonel LN, Wilkens LR, Yoshizawa CN, Marchand L. Smoking history and survival among lung cancer patients. Cancer Causes Control 1990;1:155-63
DOI
ScienceOn
|
11 |
Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T. Mutation of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64:8919-23
DOI
ScienceOn
|
12 |
Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7
DOI
PUBMED
ScienceOn
|
13 |
Hirsch FR, Skov BG. Neuroendocrine characteristics in bronchogenic adenocarcinoma and its clinical relevance. Lung Cancer 1993;10:209
DOI
ScienceOn
|
14 |
Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004;126:347-51
DOI
ScienceOn
|
15 |
Mazzone PJ, Mekhail T, Arroliga AC. Is lung cancer in nonsmoker a different disease? Chest 2004;126:326-9
DOI
ScienceOn
|
16 |
Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, Rosell R, Monzo M, Wu L, et al. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res 2001;61:1309-13
|
17 |
Powell CA, Spira A, Derti A, De Lisi C, LiuG, Borczuk A, et al. Gene expression in lung adenocarcinoma of smokers and nonsmokers. Am J Respir Cell Mol Biol 2003;29:157-62
DOI
ScienceOn
|
18 |
Kim JS, Park JY, Chae SC, Shin MC, Bae MS, Son JW, et al. Changing trends of clinical aspects in lung cancer from 1988 to 1996. J Korean Cancer Assoc 1999;31:112-9
|
19 |
Osann KE, Anton-Culver H, Kurosaki T, Taylor T. Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer 1993;54:44-8
DOI
ScienceOn
|
20 |
Brownson RC, Loy TS, Ingram E, Myers JL, Alavanja MC, Sharp DJ, et al. Lung cancer in nonsmoking women. Cancer 1995;75:29-33
DOI
PUBMED
ScienceOn
|
21 |
Shimayama T, Ohnoshi T, Ueoka H, Horiguchi T, Kodani T, Segawa Y, et al. Serum neuron enolase (NSE) levels in patients with non small cell lung cancer. Nippon Kyobu Shikkan Gakkai Zasshi 1992;30:1097-102
|
22 |
Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Smoking and lung cancer survival. Chest 2004;125:27-37
DOI
ScienceOn
|
23 |
Barbone F, Bovenzi M, Cavallieri F, Stanta G. Cigarette smoking and histologic type of lung cancer in men. Chest 1997;112:1474-9
DOI
ScienceOn
|
24 |
Pujol JL, Boher JM, Grenier J, Quantin X. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patient. Lung Cancer 2001;31:221-31
DOI
PUBMED
ScienceOn
|
25 |
de Perrot M, Licker M, Bouchardy C, Usel M, Robert J, Spiliopoulos A. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thoracic Cadiovasc Surg 2000;119:21-6
DOI
ScienceOn
|
26 |
Yesner R, Carter D. Pathology of carcinoma of the lung: changing patterns. Clin Chest Med 1982;3:257-89
|
27 |
Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest 2003;123:21S-49S
DOI
ScienceOn
|
28 |
Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer. Chest 2002;122:1037-57
DOI
ScienceOn
|